
AIDS Care Vol. 21; No. 5: P. 561-566 (05..09) - Friday, October 30, 2009
Lisa M. Williamson; Katie Buston; Helen Sweeting
Twenty 20-year-old women in eastern Scotland participated in in-depth interviews on the topic. The researchers used purposive sampling to select a heterogeneous group with different levels of sexual experience, representing different social backgrounds. All the interviewees had used male condoms; however, only three reported doing so consistently. The remainder of subjects had switched to other birth-control methods, chiefly the pill, though they typically returned to condom use occasionally.
"Condoms were talked about as the most readily available contraceptive method, and were most often the first contraceptive method used," the authors wrote. "The young women had ingrained expectations of use, but for most, these centered only on their new or casual partners, with whom not using condoms was thought to be irresponsible." The women's trust in condoms was lessened by the fact that reports of condom failure, dislike, and negative experiences were common.
The STI prevention offered by condoms was rated as important but was secondary to pregnancy prevention. Condom use declined along with the perceived risk of STIs in relationships with boyfriends.
"The promotion of condoms for STI prevention alone fails to consider the wider influences of partners and young women's negative experiences of the method," the authors concluded. "Focusing on the development of condom negotiation skills alone will not address these issues. Interventions to counter dislike, method failure, and the limits of normalization of condom use should be included in STI prevention efforts."
091030
AD091870
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.